Second, and perhaps more useful as drug evaluation tools, are ERPs
They include: feeling or being sick diarrhoea constipation These side effects are more likely to occur when the treatment first starts or when the dose increases
Clinical studies show that it can lead to significant weight loss, with patients experiencing noticeable reductions in body weight, especially when combined with a reduced-calorie diet and exercise
ISSN 0362-4331
Read more about these declaratory orders and ongoing litigation surrounding compounding GLP-1 medications in our prior blog posts, GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List and GLP-1 Drugs: FDA Sued Over Removing Tirzepatide from the Drug Shortage List. In response, state regulators have released updated guidance directed at providers, pharmacies, and outsourcing pharmacies regarding the production and distribution of these compounded medications
Biomaterials 31 , 17871797 (2010)